Researchers Develop Key to Effective RSV Vaccine: HIV and influenza next up

Scientists from the Scripps Research Institute, Calafornia, US, have created vital ingredients for an effective vaccination against respiratory syncytial virus (RSV) through a new method they have developed for producing artificial proteins. As reported in Nature on February the 5th, using a ‘rational design’ method researchers produced designer proteins which¬†stimulate the production of the desired virus-neutralizing antibodies for RSV in …